JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
CoStar Group, Inc. Announces Pricing of Common Stock Offering
-
Advanced Accelerator Applications (AAAP)/Novartis Deal Would Make Sense, But Timing is a Potential Obstacle; Worth $100+ in Takeover - JMP
-
Deciphera Pharmaceuticals (DCPH) IPO Opens Up 18%
-
Western Asset Mortgage Capital Corporation Announces Pricing Of $100,000,000 Of Convertible Senior Notes Due 2022
-
Cloudera, Inc. (CLDR) Prices 13.4M Share Follow-On Offering at $16.45/Sh; 3M Shares from Cloudera, 10.4M Shares from Selling Stockholders
-
Deciphera Pharmaceuticals Inc. (DCPH) Prices 7.5M Share IPO at $17/Sh
-
JMP Securities Upgrades Syros Pharmaceuticals (SYRS) to Market Outperform
-
Cloudera Announces Pricing of Follow-on Offering
-
Deciphera Pharmaceuticals Announces Pricing of Initial Public Offering
-
Western Asset Mortgage Capital (WMC) Reports $100M Proposed Public Offering Of Convertible Senior Notes Due 2022
-
Western Asset Mortgage Capital Corporation Announces Proposed Public Offering Of Convertible Senior Notes Due 2022
-
Neovasc (NVCN) Has a Working Transfemoral Delivery System Prototype - JMP
-
Twilio (TWLO): Amazon Seesaws Twilio - JMP
-
Ubiquiti Networks (UBNT) Distribution Model Challenges Remain Concerning - JMP Securities
-
Engagio Launches ‘Dash Account Based Attribution’ to Help Marketers Measure and Understand the Impact of ABM Initiatives
-
Axovant Sciences (AXON) PT Lowered to $19 at JMP Securities
-
ProQR Therapeutics N.V. (PRQR) PT Raised to $20 at JMP Securities
-
Cloudera, Inc. (CLDR) Reports 12M Common Stock Offering, Including 9M for Selling Stockholders
-
Cloudera Announces Launch of Proposed Follow-on Offering
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $140 at JMP Securities; Sees Minimal to Modest Sales Impact
-
Neovasc (NVCN) Court Documents Suggest a Major Catalyst is Forthcoming, Possibly a Sale - JMP Securities
-
First Solar (FSLR) to Benefit from Section 201 Injury Finding; PT Trimmed to $65 - JMP Securities
-
MongoDB, Inc. Files Registration Statement for Proposed Initial Public Offering
-
MongoDB (MDB) Files $100M IPO
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $128 at JMP Securities
-
Adobe (ADBE) PT Raised to $157 at JMP Securities
-
Marinus Pharmaceuticals Announces closing of Public Offering of Common Stock and full exercise of underwriter’s option to purchase additional shares
-
Outreach and Engagio Announce Exclusive Partnership to Deliver the Industry's First Unified Solution for Account-Based Sales and Marketing
-
JMP Securities Downgrades Silver Spring Networks (SSNI) to Market Perform Following Acquisition
-
JMP Securities Starts PJT Partners (PJT) at Market Outperform
-
Cloudera Files Registration Statement for Proposed Follow-on Offering
-
Summit Therapeutics Announces Exercise of Underwriters’ Over-Allotment Option
-
Marinus Pharma (MRNS) Prices 9.33M Common Stock Offering at $3.75/Share
-
Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Marinus Pharmaceuticals (MRNS) to Offer Common Stock
-
Marinus Pharmaceuticals Announces Public Offering of Common Stock
-
Summit Therapeutics plc (SMMT) Prices 1.46M ADS Offering at $12/Sh
-
Summit Therapeutics Announces Pricing of Public Offering of 1,459,000 American Depositary Shares
-
Summit Therapeutics (SMMT) Announces Offering of $15M of ADSs
-
Summit Therapeutics Announces Proposed Public Offering of $15.0 Million of American Depositary Shares
-
Red Hat (RHT): Datapoints From Open Source Summit, Raising PT - JMP
-
Goldman Sachs (GS) Growth Opportunities 'Largely Incremental, Not Transformational' - JMP
-
Marinus Pharmaceuticals (MRNS) PT Raised to $11 at JMP Securities, Positvely Revises EPS Estimate
-
Marinus Pharmaceuticals (MRNS) PT Raised to $11 at JMP Securities
-
Independence Realty Trust, Inc. Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
-
JMP Securities Upgrades Alleghany Corp. (Y) to Market Outperform, Negatively Revises FY 2017/2018 EPS Estimate
-
JMP Securities Starts Savara (SVRA) at Market Outperform
-
Aclaris Therapeutics (ACRS): Bullish KOL Call - JMP
-
Alteryx (AYX) Announces 8M Share Follow-On Offering at $21.25/Sh
-
Alteryx Announces Pricing of Follow-on Public Offering

